2021
September 15, 2021
Prime’s High-Value Pharmacist Managed Care pilots win PBMI Excellence Award
Pilots achieve proven ROI for high-touch pharmacist services.
September 8, 2021
Prime leaders appear on PCMA’s podcast on topic “Understanding the value of biosimilars”
Prime’s Dr. Joseph Leach and Jarrod Henshaw discuss the opportunity, how the company’s new MedDriveTM medical drug management product will help manage growing specialty spend.
September 8, 2021
Prime employees gave more than $1 million to Children’s Minnesota
Prime Therapeutics (Prime) celebrates a milestone in its employee giving program -- $1 million in donations to Children’s Minnesota. In addition to funds raised, Prime has also sponsored private patient rooms, iPads, computers and events.
August 31, 2021
Prime’s “Radical Welcomeness” approach to onboarding employees receives national recognition
New employee onboarding program earned a bronze medal from Brandon Hall, a research and analyst firm that aims to inspire a better workplace.
August 31, 2021
Prime Sees Major Spike in Telemedicine-Based Rx Fraud
By: Jane Anderson | As published in AIS’s Radar on Drug Benefits on Aug. 26, 2021 (Content reprinted with permission. Original article available on AIS’s website, available by subscription only.)
August 26, 2021
Prime discusses strategies to cost mitigation
Conference of Consulting Actuaries (CCA) hosts health plan and PBM webinar.
August 26, 2021
Prime Therapeutics named a 2021 Best Places to Work recipient in New Mexico
Award highlights great morale, engagement and retention.
August 26, 2021
Prime Therapeutics named a 2021 Best and Brightest in Wellness winner
Prime is one of 35 U.S. companies honored for its commitment to employee health and wellness.
August 11 , 2021
September 2021 decisions expected from the FDA
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of September.
August 5, 2021
Prime supports initiative to end the HIV epidemic by 2030
Promotes patient access to preventive care from any pharmacy at no cost.
July 12, 2021
August 2021 decisions expected from the FDA
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of August.
June 25, 2021
Supporting U.S. troops through great leadership
Prime Therapeutics employee recently honored with the Patriotic Employer award.
June 21, 2021
Prime Therapeutics recognized as Star Tribune National Standard Top Workplace
The Minneapolis Star Tribune recently named Prime Therapeutics a 2021 National Standard Top Workplace.
June 18, 2021
Three Minutes with April Kunze, Senior Director of Clinical Program Development
Hear about how Prime finds savings in Blue + Prime alignment and a total drug management strategy.
June 15, 2021
CellTrans' Lantidra (donislecel) approaches a decision from the FDA
Lantidra (donislecel) is being evaluated for use in brittle type 1 diabetes, a rare, difficult-to-control form of diabetes. This cell therapy was developed through a collaborative effort between CellTrans, Inc. and the University of Illinois at Chicago. PDUFA decision is expected in August 2021.
June 14, 2021
Prime’s Sheri Beck recognized by Twin Cities Business as “Notable LGBTQA Executive”
Award highlights Prime’s commitment to inclusion.
June 12, 2021
July 2021 decisions expected from the FDA
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of July.
May 17, 2021
Prime makes list in 2021 for the third time, in part due to its employee engagement initiatives.
May 12, 2021
June 2021 decisions expected from the FDA
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of June.
May 6, 2021
Getting biosimilars to market - what works and what doesn’t
Part 3: Case study: How to make the move to biosimilars. Shifting the market can be slow going.
April 30, 2021
Prime named 2021 Minnesota Women Lawyers Leadership Award recipient
Support for women in the workplace celebrated.
April 30, 2021
A conversation with Stuart Meyerson, vice president of sales, Prime Therapeutics.
April 29, 2021
Top ten acronyms in drug pipeline content
Part 2: As specified in the BPCIA, the ABLA, which is like a BLA short form, goes to the FDA. Wait, what?
April 23, 2021
Ground yourself in biosimilar basics
Part 1: News about biosimilars is everywhere. Sometimes you just need the basics. What’s what in biosimilars? Compare and contrast.
April 23, 2021
Prime pharmacists address AMCP virtual conference as keynote speakers
Catherine Starner, PharmD and Nicole Kjesbo, PharmD discuss the specialty drug pipeline and forecast.
April 12, 2021
May 2021 decisions expected from the FDA
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of May.
April 9, 2021
Erin Feigal, chief human resources officer, named Changemaker of the Year
Dakota County Regional Chamber celebrates winners at annual WomEn's Leadership Forum
April 7, 2021
Prime Therapeutics reaffirmed commitment to community giving and service in 2020
Prime’s passion for helping people goes beyond health care.
March 24, 2021
Learn about Prime’s FWA efforts with Anne Mack, senior director, network compliance.
March 23, 2021
A view of COVID-19’s pressure on the health care system
Prime responds to COVID-19: focusing on new types of fraud; extending refills and prior authorizations.
March 12, 2021
April 2021 decisions expected from the FDA
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of April.
March 8, 2021
Assisting members during Winter Storm Uri
Prime and its specialty pharmacy partners worked together to help members get their medication during the recent, historic winter storm.
March 4, 2021
Prime pharmacists volunteer in COVID-19 vaccine distribution
Pharmacy benefit manager’s pharmacists are trained, authorized to administer vaccines.
February 26, 2021
Prime Therapeutics named to nation's list of Best and Brightest Companies in Wellness®
Award celebrates companies’ innovative human resources practices, leading to improved quality of life for employees and community.
February 18, 2021
New Year, New Government Leaders: what will health care legislation look like in 2021
A conversation with David Root, vice president, Prime Therapeutics government affairs.
February 17, 2021
Prime maintains CEO Cancer Gold Standard designation
Accreditation from CEO Roundtable on Cancer continues since 2012.
February 12, 2021
March 2021 decisions expected from the FDA
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of March.
January 8, 2021
Whitney Harvey named Prime’s new diversity, equity, and inclusion director
Prime’s diversity journey continues to grow.